Boehringer Ingelheim
Boehringer Ingelheim is a global pharmaceutical company headquartered in Ingelheim am Rhein, Germany. Founded in 1885 by Albert Boehringer, the company has grown to become one of the world's leading research-driven pharmaceutical enterprises.
History[edit]
The company was established by Albert Boehringer in 1885 in the small town of Ingelheim am Rhein. Initially, the company focused on the production of tartaric acid salts, which were used in the food industry. In 1893, Boehringer discovered that lactic acid could be produced in large quantities through bacterial fermentation, marking a significant milestone in the company's history.
In 1917, Boehringer Ingelheim patented its first pharmaceutical product, a baking powder called Boeson. This marked the company's entry into the pharmaceutical industry.
Research and Development[edit]
Boehringer Ingelheim is renowned for its commitment to research and development (R&D). The company invests a significant portion of its revenue into R&D, focusing on areas such as respiratory diseases, cardiometabolic diseases, oncology, and diseases of the central nervous system.
Global Presence[edit]
Boehringer Ingelheim operates globally, with a presence in over 100 countries. The company employs more than 50,000 people worldwide and has a strong commitment to improving human and animal health.
Products[edit]
The company's product portfolio includes prescription medicines, consumer health care products, and animal health products. Some of its well-known products include Spiriva, Pradaxa, and NexGard.
Corporate Social Responsibility[edit]
Boehringer Ingelheim is committed to corporate social responsibility, focusing on sustainable development, environmental protection, and social engagement. The company supports various initiatives aimed at improving health care access and education in underserved communities.
Headquarters[edit]
The company's headquarters are located in Ingelheim am Rhein, Germany. The site includes state-of-the-art research facilities and serves as the central hub for the company's global operations.
Related pages[edit]
Sponsored Health Resource
W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
